C-erbB-2 overexpression and survival in early onset breast cancerAGRUP, Mans; STAL, Olle; OLSEN, Karen et al.Breast cancer research and treatment. 2000, Vol 63, Num 1, pp 23-29, issn 0167-6806Article

Abnormal expression of 17β-hydroxysteroid dehydrogenases in breast cancer predicts late recurrenceGUNNARSSON, Cecilia; OLSSON, Birgit M; STAL, Olle et al.Cancer research (Baltimore). 2001, Vol 61, Num 23, pp 8448-8451, issn 0008-5472Article

Estrogen Receptor-a Phosphorylation at Serine 305, Nuclear p21-Activated Kinase 1 Expression, and Response to Tamoxifen in Postmenopausal Breast CancerBOSTNER, Josefine; SKOOG, Lambert; FORNANDER, Tommy et al.Clinical cancer research (Print). 2010, Vol 16, Num 5, pp 1624-1633, issn 1078-0432, 10 p.Article

Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-upRYDEN, Lisa; JIRSTRÖM, Karin; HAGLUND, Monica et al.Breast cancer research and treatment. 2010, Vol 120, Num 2, pp 491-498, issn 0167-6806, 8 p.Article

A comparison between flow cytometric assessment of S-phase fraction and Nottingham histologic grade as prognostic instruments in breast cancerSUNDQUIST, Marie; THORSTENSON, Sten; BRUDIN, Lars et al.Breast cancer research and treatment. 2000, Vol 63, Num 1, pp 11-15, issn 0167-6806Article

Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survivalSHABO, Ivan; STAL, Olle; OLSSON, Hans et al.International journal of cancer. 2008, Vol 123, Num 4, pp 780-786, issn 0020-7136, 7 p.Article

Expression of the forkhead transcription factor FOXL2 correlates with good prognosis in breast cancer patients treated with tamoxifenWEGMAN, Pia; EREMO, Anna Göthlin; LINDLÖF, Angelica et al.International journal of oncology. 2011, Vol 38, Num 4, pp 1145-1151, issn 1019-6439, 7 p.Article

17ss-Hydroxysteroid dehydrogenase type 1 as predictor of tamoxifen response in premenopausal breast cancerKÄLLSTRÖM, Ann-Christine; SALME, Rebecka; RYDEN, Lisa et al.European journal of cancer (1990). 2010, Vol 46, Num 5, pp 892-900, issn 0959-8049, 9 p.Article

Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patientsHOLM, Caroline; RAYALA, Suresh; JIRSTRÖM, Karin et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 10, pp 671-680, issn 0027-8874, 10 p.Article

Sulfotransferase1A1 and risk of postmenopausal breast cancerJEREVALL, Piiha-Lotta; AHMADI, Ahmad; BERGMAN, Malin et al.Anticancer research. 2005, Vol 25, Num 3C, pp 2515-2517, issn 0250-7005, 3 p.Article

Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancerWALTERSSON, Marie Ahnström; ASKMALM, Marie Stenmark; NORDENSKJÖLD, Bo et al.International journal of oncology. 2009, Vol 34, Num 2, pp 441-448, issn 1019-6439, 8 p.Article

Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistanceAHNSTRÖM, Marie; NORDENSKJÖLD, Bo; RUTQVIST, Lars Erik et al.Breast cancer research and treatment. 2005, Vol 91, Num 2, pp 145-151, issn 0167-6806, 7 p.Article

HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, informationRYDEN, Lisa; LANDBERG, Göran; STAL, Olle et al.Breast cancer research and treatment. 2008, Vol 109, Num 2, pp 351-357, issn 0167-6806, 7 p.Article

p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patientsWEGMAN, Pia; STAL, Olle; ASKMALM, Marie Stenmark et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 5, pp 347-351, issn 1744-6872, 5 p.Article

Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancerADELL, Gunnar; HONG ZHANG; JANNSSON, Agneta et al.International journal of radiation oncology, biology, physics. 2001, Vol 50, Num 3, pp 659-663, issn 0360-3016Article

Protein accumulation and gene mutation of p53 in bilateral breast cancerSTENMARK-ASKMAIM, Marie; GENTILE, Massimiliano; WINGREN, Sten et al.Acta oncologica (Stockholm). 2001, Vol 40, Num 1, pp 56-62, issn 0284-186XArticle

17β-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancerJANSSON, Agneta K; GUNNARSSON, Cecilia; COHEN, Maja et al.Cancer research (Baltimore). 2006, Vol 66, Num 23, pp 11471-11477, issn 0008-5472, 7 p.Article

Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer PatientsJANSSON, Agneta; DELANDER, Lovisa; GUNNARSSON, Cecilia et al.Clinical cancer research (Print). 2009, Vol 15, Num 10, pp 3610-3616, issn 1078-0432, 7 p.Article

Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with Cyclin D1 gene amplificationJIRSTRÖM, Karin; STENDAHL, Maria; RYDEN, Lisa et al.Cancer research (Baltimore). 2005, Vol 65, Num 17, pp 8009-8016, issn 0008-5472, 8 p.Article

PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancerKOK, Marleen; ZWART, Wilbert; LANDBERG, Göran et al.Breast cancer research and treatment. 2011, Vol 125, Num 1, pp 1-12, issn 0167-6806, 12 p.Article

Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast CancerMILLER MARIANELA PEREZ-TORRES, Todd W; NARASANNA, Archana; ARTEAGA, Carlos L et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 10, pp 4192-4201, issn 0008-5472, 10 p.Article

p27^Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patientsSTENDAHL, Maria; NILSSON, Sofie; WIGERUP, Caroline et al.International journal of cancer (Print). 2010, Vol 127, Num 12, pp 2851-2858, issn 0020-7136, 8 p.Article

Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancerPEREZ-TENORIO, Gizeh; KARLSSON, Elin; WALTERSSON, Marie Ahnström et al.Breast cancer research and treatment. 2011, Vol 128, Num 3, pp 713-723, issn 0167-6806, 11 p.Article

Cytoplasmic p21^WAF1/CIP1 correlates with Akt activation and poor response to tamoxifen in breast cancerPEREZ-TENORIO, Gizeh; BERGLUND, Fredrik; ESGUERRA MERCA, Anna et al.International journal of oncology. 2006, Vol 28, Num 5, pp 1031-1042, issn 1019-6439, 12 p.Article

Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancerRYDEN, Lisa; JIRSTRÖM, Karin; BENDAHL, Pär-Ola et al.Journal of clinical oncology. 2005, Vol 23, Num 21, pp 4695-4704, issn 0732-183X, 10 p.Article